Role of the venous return in critical illness and shock: Part ii-shock and mechanical ventilation

Critical Care Medicine

Volumn 41, Issue 2, 2013, Pages 573-579

  Funk, Duane J ^a   Jacobsohn, Eric ^a   Kumar, Anand ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Department of Anesthesiology   (United States)

Author keywords

cardiogenic shock; cardiovascular physiology; hemodynamics; hemorrhagic shock; obstructive shock; septic shock

Indexed keywords

CATECHOLAMINE; DOBUTAMINE; INOTROPIC AGENT; MILRINONE; PHOSPHODIESTERASE INHIBITOR;

ARTIFICIAL VENTILATION; BLEEDING; BLOOD VESSEL FUNCTION; BLOOD VOLUME; CAPILLARY RESISTANCE; CARDIOGENIC SHOCK; CARDIOVASCULAR FUNCTION; CRITICAL ILLNESS; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RIGHT ATRIUM; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE; HEART VENTRICLE FUNCTION; HEMODYNAMIC MONITORING; HEMORRHAGIC SHOCK; HUMAN; HYPOTENSION; HYPOVOLEMIA; HYPOVOLEMIC SHOCK; MEAN ARTERIAL PRESSURE; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SEPTIC SHOCK; SHOCK; VASODILATATION; VENOUS RETURN;

BLOOD PRESSURE; CARDIAC OUTPUT; CARDIOTONIC AGENTS; CATECHOLAMINES; CORONARY CIRCULATION; CRITICAL ILLNESS; CYTOKINES; FLUID THERAPY; HUMANS; HYPOVOLEMIA; NITRIC OXIDE; PNEUMOTHORAX; POSITIVE-PRESSURE RESPIRATION; SHOCK; STROKE VOLUME; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION;

EID: 84873409513     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31827bfc25     Document Type: Review

References (53)

1. Greenway CV, Lister GE: Capacitance effects and blood reservoir function in the splanchnic vascular bed during non-hypotensive haemorrhage and blood volume expansion in anaesthetized cats. J Physiol (Lond) 1974; 237:279-294
2. Guyton AC: Determination of cardiac output by equating venous return curves with cardiac response curves. Physiol Rev 1955; 35:123-129
3. Hainsworth R: Vascular capacitance: Its control and importance. Rev Physiol Biochem Pharmacol 1986; 105:101-173
4. Milnor W: Cardiovascular Physiology. New York, Oxford University Press, 1990
5. Noble BJ, Drinkhill MJ, Myers DS, et al: Mechanisms responsible for changes in abdominal vascular volume during sympathetic nerve stimulation in anaesthetized dogs. Exp Physiol 1997; 82:925-934
6. Rothe CF: Refex control of veins and vascular capacitance. Physiol Rev 1983; 63:1281-1342
7. Magder S, De Varennes B: Clinical death and the measurement of stressed vascular volume. Crit Care Med 1998; 26:1061-1064
8. Holcroft JW: Impairment of venous return in hemorrhagic shock. Surg Clin North Am 1982; 62:17-29
9. Keele C, Samson N: Wright's Applied Physiology. 11th Edition. Oxford Medical Publications, Oxford University Press, 1965
10. Angele MK, Schneider CP, Chaudry IH: Bench-to-bedside review: Latest results in hemorrhagic shock. Crit Care 2008; 12:218
11. Peitzman AB, Billiar TR, Harbrecht BG, et al: Hemorrhagic shock. Curr Probl Surg 1995; 32:925-1002
12. Md S, Moochhala SM, Siew-Yang KL: The role of inducible nitric oxide synthase inhibitor on the arteriolar hyporesponsiveness in hemorrhag-ic-shocked rats. Life Sci 2003; 73:1825-1834
13. Thiemermann C, Szabó C, Mitchell JA, et al: Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemor-rhagic shock is mediated by nitric oxide. Proc Natl Acad Sci USA 1993; 90:267-271
14. Zingarelli B, Caputi AP, Di Rosa M: Dexamethasone prevents vascular failure mediated by nitric oxide in hemorrhagic shock. Shock 1994; 2:210-215
15. Lehtonen LA, Antila S, Pentikäinen PJ: Pharmacokinetics and phar-macodynamics of intravenous inotropic agents. Clin Pharmacokinet 2004; 43:187-203
16. Petersen JW, Felker GM: Inotropes in the management of acute heart failure. Crit Care Med 2008; 36(1 Suppl):S106-S111
17. Geerts B F, Maas JJ, Aarts LP, et al: Partitioning the resistances along the vascular tree: Effects of dobutamine and hypovolemia in piglets with an intact circulation. J Clin Monit Comput 2010; 24:377-384
18. Ogilvie RI: Effects of inotropic agents on arterial resistance and venous compliance in anesthetized dogs. Can J Physiol Pharmacol 1982; 60:968-976
19. DiSesa VJ, Brown E, Mudge GH Jr, et al: Hemodynamic comparison of dopamine and dobutamine in the postoperative volume-loaded, pressure-loaded, and normal ventricle. J Thorac Cardiovasc Surg 1982; 83: 256-263
20. Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet 2005; 365:63-78
21. Stearns-Kurosawa DJ, Osuchowski M F, Valentine C, et al: The patho-genesis of sepsis. Annu Rev Pathol 2011; 6:19-48
22. Cauwels A: Nitric oxide in shock. Kidney Int 2007; 72:557-565
23. Cobb J P, Danner RL: Nitric oxide and septic shock. JAMA 1996; 275:1192-1196
24. Kilbourn RG, Gross SS, Jubran A, et al: NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990; 87: 3629-3632
25. Szabo C, Wu CC: Role of nitric oxide in the development of vascular contractile dysfunction in circulatory shock. J Med Sci 2011; 31:001-016
26. Titheradge MA: Nitric oxide in septic shock. Biochim Biophys Acta 1999; 1411:437-455
27. Kumar A, Brar R, Wang P, et al: Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol 1999; 276(1 Pt 2):R265-R276
28. Kumar A, Thota V, Dee L, et al: Tumor necrosis factor alpha and in-terleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996; 183:949-958
29. Bressack MA, Morton NS, Hortop J: Group B streptococcal sepsis in the piglet: Effects of fuid therapy on venous return, organ edema, and organ blood fow. Circ Res 1987; 61:659-669
30. Hiesmayr M, Jansen JR, Versprille A: Effects of endotoxin infusion on mean systemic flling pressure and fow resistance to venous return. Pfugers Arch 1996; 431:741-747
31. Magder S, Vanelli G: Circuit factors in the high cardiac output of sepsis. J Crit Care 1996; 11:155-166
32. Madger S: Shock physiology. In: Pathophysiologic Foundations of Critical Care. Pinsky MR, Vincent JF (Eds). Baltimore, MD: Williams and Wilkins, 1993, pp 140-160
33. Pope JV, Jones AE, Gaieski D F, et al Emergency Medicine Shock Research Network (EMShockNet) Investigators: Multicenter study of central venous oxygen saturation (ScvO(2)) as a predictor of mortality in patients with sepsis. Ann Emerg Med 2010; 55:40-46.e1
34. Nguyen HB, Rivers E P, Knoblich BP, et al: Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004; 32:1637-1642
35. Donnino M, Nguyen HB, Rivers EP: A hemodynamic comparison of early and late phase severe sepsis and septic shock. Chest 2002; 122:5S
36. Finfer S, Bellomo R, Boyce N, et al; SAFE Study Investigators: A comparison of albumin and saline for fuid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256
37. Rackow EC, Kaufman BS, Falk JL, et al: Hemodynamic response to fuid repletion in patients with septic shock: Evidence for early depression of cardiac performance. Circ Shock 1987; 22:11-22
38. Rivers E, Nguyen B, Havstad S, et al; Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
39. Blain CM, Anderson TO, Pietras RJ, et al: Immediate hemodynamic effects of gram-negative vs gram-positive bacteremia in man. Arch Intern Med 1970; 126:260-265
40. Kumar A, Haery C, Parrillo JE: Myocardial dysfunction in septic shock: Part I. Clinical manifestation of cardiovascular dysfunction. J Cardio-thorac Vasc Anesth 2001; 15:364-376
41. MacLean LD, Mulligan WG, McLean AP, et al: Patterns of septic shock in man-A detailed study of 56 patients. Ann Surg 1967; 166:543-562
42. Weil MH, Nishjima H: Cardiac output in bacterial shock. Am J Med 1978; 64:920-922
43. Jardin F, Fourme T, Page B, et al: Persistent preload defect in severe sepsis despite fuid loading: A longitudinal echocardiographic study in patients with septic shock. Chest 1999; 116:1354-1359
44. Parker MM, McCarthy KE, Ognibene F P, et al: Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990; 97:126-131
45. Parker MM, Shelhamer JH, Bacharach SL, et al: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100:483-490
46. Jacobsohn E, Chorn R, O'Connor M: The role of the vasculature in regulating venous return and cardiac output: Historical and graphical approach. Can J Anaesth 1997; 44:849-867
47. Luecke T, Pelosi P, Quintel M: [Haemodynamic effects of mechanical ventilation]. Anaesthesist 2007; 56:1242-1251
48. Marik PE, Baram M, Vahid B: Does central venous pressure predict fuid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008; 134:172-178
49. Kumar A, Anel R, Bunnell E, et al: Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular flling volume, cardiac performance, or the response to volume infusion in normal subjects. Crit Care Med 2004; 32:691-699
50. Küntscher MV, Germann G, Hartmann B: Correlations between cardiac output, stroke volume, central venous pressure, intra-abdominal pressure and total circulating blood volume in resuscitation of major burns. Resuscitation 2006; 70:37-43
51. Marik PE, Monnet X, Teboul JL: Hemodynamic parameters to guide fuid therapy. Ann Intensive Care 2011; 1:1
52. Michard F, Chemla D, Richard C, et al: Clinical use of respiratory changes in arterial pulse pressure to monitor the hemodynamic effects of PEEP. Am J Respir Crit Care Med 1999; 159:935-939
53. Osman D, Ridel C, Ray P, et al: Cardiac flling pressures are not appropriate to predict hemodynamic response to volume challenge. Crit Care Med 2007; 35:64-68